These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17673427)

  • 1. 18F-FDG PET in planning radiation treatment of non-small cell lung cancer: where exactly is the tumor?
    Dahele MR; Ung YC
    J Nucl Med; 2007 Aug; 48(8):1402; author reply 1403. PubMed ID: 17673427
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic threshold for radiation target volume by PET/CT.
    Wong CY; Mahajan P; Yan D
    J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
    [No Abstract]   [Full Text] [Related]  

  • 4. PET and PET-CT in radiation treatment planning for lung cancer.
    Aristei C; Falcinelli L; Palumbo B; Tarducci R
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
    Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
    Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.
    Remonnay R; Morelle M; Pommier P; Giammarile F; Carrère MO
    Int J Technol Assess Health Care; 2008; 24(2):212-20. PubMed ID: 18400125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
    Bradley JD; Perez CA; Dehdashti F; Siegel BA
    J Nucl Med; 2004 Jan; 45 Suppl 1():96S-101S. PubMed ID: 14736840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art lung cancer radiation therapy.
    Belderbos J; Sonke JJ
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1353-63. PubMed ID: 19827995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical review of PET-CT for radiotherapy planning in lung cancer.
    Senan S; De Ruysscher D
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET scans in radiotherapy planning of lung cancer.
    De Ruysscher D; Kirsch CM
    Radiother Oncol; 2010 Sep; 96(3):335-8. PubMed ID: 20656364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
    Mac Manus MP
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for the use of PET-CT with 18F-FDG in radiotherapy planning].
    García Vicente AM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):364. PubMed ID: 23063325
    [No Abstract]   [Full Text] [Related]  

  • 17. Personnel radiation dose considerations in the use of an integrated PET-CT scanner for radiotherapy treatment planning.
    Carson KJ; Young VA; Cosgrove VP; Jarritt PH; Hounsell AR
    Br J Radiol; 2009 Nov; 82(983):946-9. PubMed ID: 19332513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
    Chiti A; Kirienko M; Grégoire V
    Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of 18F-FDG PET in oncology: clinical and resource implications.
    Al-Nahhas A; Win Z; Singh A; Khan S; Al-Sayed Y
    Nucl Med Rev Cent East Eur; 2006; 9(1):1-5. PubMed ID: 16791796
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung tumor segmentation in PET images using graph cuts.
    Ballangan C; Wang X; Fulham M; Eberl S; Feng DD
    Comput Methods Programs Biomed; 2013 Mar; 109(3):260-8. PubMed ID: 23146420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.